Sonnet BioTherapeutics Holdings, Inc.
SONN
$3.47
$0.092.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.76% | -57.67% | 34.78% | 60.51% | 64.65% |
| Total Depreciation and Amortization | 8.77% | 10.00% | 10.21% | 9.63% | 9.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.36% | 168.27% | 56.06% | 15.98% | -9.12% |
| Change in Net Operating Assets | 188.95% | 110.21% | 106.44% | 40.01% | -128.70% |
| Cash from Operations | -3.14% | 11.28% | 54.50% | 59.67% | 56.59% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.41% | 86.81% | 97.29% | 97.29% | 13.99% |
| Cash from Investing | 93.41% | 86.81% | 97.29% | 97.29% | 13.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 13.06% | 88.59% | -46.93% | -67.17% | -69.82% |
| Repurchase of Common Stock | -23.16% | -23.16% | -23.16% | -23.16% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -301.16% | -5,430.00% | -- | -- | -- |
| Cash from Financing | 5.63% | 74.71% | -49.32% | -69.08% | -73.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.74% | 77.29% | 39.31% | -172.91% | -292.98% |